Wed, Oct 31, 2012 1:41 PM
Information on Changes in Accounting Policies
1. Registration fee of medical representatives, levied in Hungary, hereinafter will be presented as item of the general selling costs (earlier: other operating expense) 2. Held-to-maturity securities hereinafter will be presented as items of cash and cash equivalents (earlier: other financial assets)

Egis Pharmaceuticals PLC (the 'Company') informs all parties concerned, that two changes have been introduced in the accounting policies of the Company. Both modifications mean only changes in classification thus affect neither the Company’s net profit nor the total value of assets and equity and liabilities. In the upcoming interim report to be disclosed by the Company data will already be presented according to the new classification.

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox